In the offering, Ossur hf. is selling 63,391,690 new shares for ISK 81 per share, resulting in proceeds of ISK 5,135 million. Kaupthing Bank - Investment Banking is managing the offering which is a part of the financing of Ossur hf.'s acquisition of the US company Royce Medical Holdings Inc.
Simultaneously to the offering and on the same terms, Ossur hf. today sold 3,107,757 new shares for ISK 252 million to 31 managers at Össur hf.
The share offering and sale to managers result in a 20.9% increase in Ossur hf.'s share capital.
The due date of payment for new shares is Thursday 29 September 2005 and payment shall be made no later than on Tuesday 4 October 2005. Notification of allocation and payment instructions can be obtained from the offering website at www.kbbanki.is, but will also be sent to investors.
About Ossur
Ossur (Icelandic Stock Exchange: OSSR) is a trusted and global leader in the development, manufacturing, distribution, sales and marketing of high technology orthopaedic and prosthetic devices. With its head office in Reykjavik, Iceland, the company's U.S. sales and marketing headquarters are located in Aliso Viejo, California; the Canadian office in Vancouver, BC; the Nordic office in Uppsala, Sweden; and the European office in Eindhoven, Holland. The company has a considerable distribution network in other markets and has over 900 employees worldwide. Given its mission to offer people a life without limitations, Ossur allocates an industry record of approximately eight percent of its revenue on medical technology research and development, and provides extensive education programs through the Ossur Academy. The company also sponsors a variety of community outreach programs and non-profit organizations. Website: www.ossur.com.
Enquiries:
Jón Sigurðsson, President & CEO of Ossur hf. on tel. +354 515-1316
Örvar Kærnested, Managing Director of Kaupting Bank - Investment Banking on tel. +354 856-6814
Ossur provides a number of investor communications via email.
To be kept up-to-date with the latest developments and financial reports from Ossur, please subscribe the Investor Mailinglist: http://www.ossur.com/template1.asp?pageid=233